Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTION: Full Anticoagulation in Hospitalized COVID-19 Patients
NCT04394377Phase 4Completed
- Sponsor
- Brazilian Clinical Research Institute
- Start
- Jun 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in coronavirus disease 2019 (COVID-19), sponsored by Brazilian Clinical Research Institute. Started Jun 2020; status: completed.
02
Drugs
rivaroxaban
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04394377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04394377.